BioStem Technologies (BSEM) News Today → What’s Really Next for America… (From Porter & Company) (Ad) Free BSEM Stock Alerts 9.01 -0.69 (-7.11%) (As of 05/16/2024 09:01 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 4:32 PM | finance.yahoo.comBSEM Again Bests Estimates as Growth AcceleratesMay 15 at 5:23 AM | finance.yahoo.comBioStem Technologies Inc (BSEM) Q1 2024 Earnings Call Transcript Highlights: A Remarkable ...May 14 at 4:01 PM | globenewswire.comBioStem Technologies Reports Record First Quarter Revenue of $41.9 MillionMay 12, 2024 | americanbankingnews.comBioStem Technologies, Inc. (OTCMKTS:BSEM) Sees Large Decrease in Short InterestApril 30, 2024 | globenewswire.comBioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain AllograftsApril 26, 2024 | marketbeat.comBioStem Technologies, Inc. (OTCMKTS:BSEM) Short Interest Up 152.7% in AprilBioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 37,400 shares, a growth of 152.7% from the March 31st total of 14,800 shares. Based on an average daily volume of 68,700 shares, the days-to-cover ratio is presently 0.5 days.April 24, 2024 | globenewswire.comBioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior ExchangeApril 4, 2024 | marketbeat.comBioStem Technologies, Inc. to Post Q1 2024 Earnings of $0.74 Per Share, Zacks Small Cap Forecasts (OTCMKTS:BSEM)BioStem Technologies, Inc. (OTCMKTS:BSEM - Free Report) - Investment analysts at Zacks Small Cap increased their Q1 2024 earnings per share (EPS) estimates for shares of BioStem Technologies in a report issued on Tuesday, April 2nd. Zacks Small Cap analyst B. Sorensen now expects that the companyApril 2, 2024 | finance.yahoo.comQ4 2023 Biostem Technologies Inc Earnings CallApril 2, 2024 | finance.yahoo.comBSEM Continues to Post Stellar ResultsApril 1, 2024 | globenewswire.comBioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY IncreaseMarch 21, 2024 | globenewswire.comBioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024March 9, 2024 | seekingalpha.comBSEM BioStem Technologies, Inc.March 9, 2024 | finance.yahoo.comBioStem Technologies, Inc. (BSEM)March 1, 2024 | morningstar.comBioStem Technologies Inc BSEMFebruary 6, 2024 | finance.yahoo.comBSEM: BioStem Expands and ImprovesFebruary 6, 2024 | finance.yahoo.comBSEM Provides Good Value for Great ScienceFebruary 6, 2024 | finance.yahoo.comBSEM Worth a Look on Surging RevenuesFebruary 6, 2024 | finance.yahoo.comBSEM Sees Increasing DemandFebruary 6, 2024 | finance.yahoo.comBSEM Crushes Estimates on Stellar GrowthFebruary 6, 2024 | finance.yahoo.comBSEM: Investors Need to Pay Attention to BSEM Get BioStem Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BSEM and its competitors with MarketBeat's FREE daily newsletter. Email Address A ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x! Just click here to learn how you can access this coin right now. BSEM Media Mentions By Week BSEM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BSEM News Sentiment▼0.490.54▲Average Medical News Sentiment BSEM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BSEM Articles This Week▼61▲BSEM Articles Average Week Get BioStem Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BSEM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Nuvectis Pharma News Today Adicet Bio News Today Elite Pharmaceuticals News Today Amylyx Pharmaceuticals News Today Cardiol Therapeutics News Today Jushi News Today Grown Rogue International News Today Cartesian Therapeutics News Today PDS Biotechnology News Today Sagimet Biosciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BSEM) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the Markets348 million Americans lives to END as we know it?The Oxford Club[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioStem Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
